Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of MYD88 L265P mutation in cerebrospinal fluid of primary CNS lymphoma patients

Leuk Lymphoma. 2023 Jun;64(6):1219-1222. doi: 10.1080/10428194.2023.2199895. Epub 2023 Apr 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Glucocorticoids / therapeutic use
  • Humans
  • Liquid Biopsy
  • Lymphoma*
  • Mutation
  • Myeloid Differentiation Factor 88 / genetics
  • Myeloid Differentiation Factor 88 / metabolism
  • Waldenstrom Macroglobulinemia* / diagnosis

Substances

  • Glucocorticoids
  • Myeloid Differentiation Factor 88